Humbles, Alison A.,Silver, Jonathan S.,Kolbeck, Roland
申请号：
AU2017254625
公开号：
AU2017254625A1
申请日:
2017.04.19
申请国别(地区):
AU
年份:
2018
代理人:
摘要：
The disclosure provides a method for treating or preventing a disease or disorder associated with lung inflammation by inhibiting the conversion of type 2 innate lymphoid cells (ILC2s) to type 1 innate lymphoid cells (ILC1s).
